SIOG2024-1-OA-001 Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT EA2186)

IF 3 3区医学 Q3 GERIATRICS & GERONTOLOGY

Journal of geriatric oncology Pub Date : 2024-10-01 DOI:10.1016/j.jgo.2024.101845

E. Dotan, P. Catalano, L. Lenchik, R. Boutin, X. Yao, J.P. Ohr, K.-H. Lim, N. Vijayvergia, S.R. Chandana, A. Kalyan, R.F. Dunne, D.B. Zhen, D. Li, M.A. Simon, J. Berlin, L.I. Wagner, P.J. O'Dwyer

引用次数: 0

查看原文本刊更多论文

SIOG2024-1-OA-001 对治疗无效的老年转移性胰腺癌患者进行的吉西他滨/Nab-紫杉醇与 5-氟尿嘧啶/亮菌甲素/脂质体伊立替康比较的随机 II 期研究（GIANT EA2186）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of geriatric oncology ONCOLOGY-GERIATRICS & GERONTOLOGY

CiteScore

5.30

自引率

10.00%

发文量

379

审稿时长

80 days

期刊介绍： The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology. The journal welcomes the submission of manuscripts in the following categories: • Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the Editor.